Loading clinical trials...
Loading clinical trials...
Triple-negative breast cancer (TNBC) is considered a tumor with a high risk of recurrence and metastasis and requires aggressive systemic therapy combining immunotherapy and chemotherapy. If the thera...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kliniken Essen-Mitte
Collaborators
NCT07264998 · Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, and more
NCT07501455 · Microbiome, Cytokines, and more
NCT05966649 · Preterm Spontaneous Labor With Preterm Delivery, Preterm Birth, and more
NCT06800833 · Gut Microbiome
NCT03325855 · Fecal Microbiota Transplantation, Clostridium Difficile Infection, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions